rifampin and Rhinitis--Atrophic

rifampin has been researched along with Rhinitis--Atrophic* in 3 studies

Trials

2 trial(s) available for rifampin and Rhinitis--Atrophic

Article	Year
Novel treatment of atrophic rhinitis: early results. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2008, Volume: 265, Issue:10 The aim of this randomized control trial, performed at a tertiary referral hospital, was to compare the therapeutic effectiveness of two novel treatment modalities, oral rifampicin and submucosal placentrex injection, in randomly selected patients of primary atrophic rhinitis regarding objective, subjective and histopathological improvement. Patients treated with oral rifampicin showed most promising results regarding objective, subjective and histopathological improvement with maximum disease-free interval on regular follow-up as compared to submucosal placentrex injections. Topics: Administration, Oral; Adolescent; Adult; Biopsy; Endoscopy; Female; Follow-Up Studies; Humans; Injections; Male; Middle Aged; Nasal Mucosa; Nucleic Acid Synthesis Inhibitors; Placental Extracts; Rhinitis, Atrophic; Rifampin; Time Factors; Treatment Outcome; Young Adult	2008
Ciprofloxacin for rhinoscleroma and ozena. Lancet (London, England), 1993, Jul-10, Volume: 342, Issue:8863 Topics: Ciprofloxacin; Female; Humans; Male; Rhinitis, Atrophic; Rhinoscleroma; Rifampin; Trimethoprim, Sulfamethoxazole Drug Combination	1993

Article

Year

Novel treatment of atrophic rhinitis: early results.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2008, Volume: 265, Issue:10

The aim of this randomized control trial, performed at a tertiary referral hospital, was to compare the therapeutic effectiveness of two novel treatment modalities, oral rifampicin and submucosal placentrex injection, in randomly selected patients of primary atrophic rhinitis regarding objective, subjective and histopathological improvement. Patients treated with oral rifampicin showed most promising results regarding objective, subjective and histopathological improvement with maximum disease-free interval on regular follow-up as compared to submucosal placentrex injections.

Topics: Administration, Oral; Adolescent; Adult; Biopsy; Endoscopy; Female; Follow-Up Studies; Humans; Injections; Male; Middle Aged; Nasal Mucosa; Nucleic Acid Synthesis Inhibitors; Placental Extracts; Rhinitis, Atrophic; Rifampin; Time Factors; Treatment Outcome; Young Adult

2008

Ciprofloxacin for rhinoscleroma and ozena.

Lancet (London, England), 1993, Jul-10, Volume: 342, Issue:8863

Topics: Ciprofloxacin; Female; Humans; Male; Rhinitis, Atrophic; Rhinoscleroma; Rifampin; Trimethoprim, Sulfamethoxazole Drug Combination

1993

Other Studies

1 other study(ies) available for rifampin and Rhinitis--Atrophic

Article	Year
[Necrotizing ethmoiditis caused by anaerobic bacteria. Apropos of a case]. JFORL. Journal francais d'oto-rhino-laryngologie; audiophonologie et chirurgie maxillo-faciale, 1974, Volume: 23, Issue:5 Topics: Clostridium Infections; Clostridium perfringens; Diagnosis, Differential; Ethmoid Sinus; Female; Humans; Middle Aged; Rhinitis, Atrophic; Rifampin; Sinusitis	1974